• 150
  • 16
  • Favorite

Pfizer reports positive results from Phase 3 study of PREVNAR 20 with COVID-19 vaccine

Seeking Alpha2022-01-12

Pfizer announces positive top-line results from a Phase 3 study describing the safety and immunogenicity of PREVNAR 20 (Pneumococcal 20-valent Conjugate Vaccine) in 570 adults in U.S. aged 65 years ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment16

  • Twinkoink
    ·2022-01-13
    Pls go up!!!!!!
    Reply
    Report
  • MayTan
    ·2022-01-13
    Great! 
    Reply
    Report
  • Jess261
    ·2022-01-13
    Okay 
    Reply
    Report
  • Miketee74
    ·2022-01-13
    Great! 
    Reply
    Report
  • iams3by
    ·2022-01-13
    Time to buy more
    Reply
    Report
  • UTOtrader
    ·2022-01-13
    Buy more Pfizer
    Reply
    Report
  • Gabrielle_20
    ·2022-01-12
    👍
    Reply
    Report
  • Sysy
    ·2022-01-12
    Nice
    Reply
    Report
  • Qisheng
    ·2022-01-12
    Nice 
    Reply
    Report
  • ahleemama
    ·2022-01-12
    Buy
    Reply
    Report
  • AA23
    ·2022-01-12
    Super like.. lol
    Reply
    Report
  • Ahleepapa
    ·2022-01-12
    Buy
    Reply
    Report
  • Delfort
    ·2022-01-12
    Thanks
    Reply
    Report
  • bhahab
    ·2022-01-12
    F
    Reply
    Report
  • weng1245
    ·2022-01-12
    Like
    Reply
    Report
  • sowtat
    ·2022-01-12
    interesting reaf
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial